Equity Overview
Price & Market Data
Price: $0.0657
Daily Change: $0.00 / 0.00%
Range: $0.0657 - $0.0659
Market Cap: $9,628,819
Volume: 70,000
Performance Metrics
1 Week: -3.18%
1 Month: -21.76%
3 Months: -68.00%
6 Months: -17.95%
1 Year: 72.51%
YTD: -8.52%
Details
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.